InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
14
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-2.8%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Galante Joseph C, Director. Insider active across 3 companies, notably Cumberland Pharmaceuticals INC. Aggregated, 26 filings have been logged. Split: 14 buys · 0 sell. Total volume traded: €70k. Activity tracked since 17 March 2021. The latest transaction was filed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Galante Joseph C
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
1,800 shares@ US$2.8017.8% of flowCommon StockSEC:0001632384-26-000002:0
1,000 shares@ US$5.1719.3% of flowCommon StockSEC:0001628280-25-013541:0
2,500 shares@ US$1.7116.1% of flowCommon StockSEC:0001628280-25-003185:0
1,000 shares@ US$1.716.4% of flowCommon StockSEC:0001214659-24-005222:0
239 shares@ US$82.7215.9% of flowPNFP Common StockSEC:0001115055-24-000054:0
1,000 shares@ US$1.927.2% of flowCommon StockSEC:0001209191-23-021278:0
174 shares@ US$74.0910.6% of flowPNFP Common StockSEC:0001567619-23-004174:0
1,000 shares@ US$72.2657.8% of flowPNFP Common StockSEC:0001567619-23-001121:0
Canonical exit: 20 Apr 2023 (T+90)
65 shares@ US$2.530.7% of flowCommon StockSEC:0001209191-22-062643:0
Canonical exit: 30 Jan 2023 (T+90)
65 shares@ US$2.330.6% of flowCommon StockSEC:0001209191-22-062651:0
Canonical exit: 1 Mar 2023 (T+90)
65 shares@ US$2.570.7% of flowCommon StockSEC:0001209191-22-057942:0
Canonical exit: 26 Dec 2022 (T+90)
65 shares@ US$2.350.6% of flowCommon StockSEC:0001209191-22-051667:0
Canonical exit: 14 Nov 2022 (T+90)
70 shares@ US$2.110.6% of flowCommon StockSEC:0001209191-22-046896:0
Canonical exit: 29 Sept 2022 (T+90)
76 shares@ US$2.050.0002% mcap1.2% of flowCommon StockSEC:0001209191-22-040094:0
Canonical exit: 30 Aug 2022 (T+90)
61 shares@ US$2.450.0002% mcap1.2% of flowCommon StockSEC:0001209191-22-035994:0
Canonical exit: 31 Jul 2022 (T+90)
56 shares@ US$2.710.6% of flowCommon StockSEC:0001209191-22-027646:0
Canonical exit: 13 Jul 2022 (T+90)
1,000 shares@ US$2.599.6% of flowCommon StockSEC:0001209191-22-026138:0
201 shares@ US$101.0815.7% of flowPNFP Common StockSEC:0001567619-22-006185:0
142 shares@ US$2.671.3% of flowCommon StockSEC:0001209191-21-067899:0
Canonical exit: 30 Jan 2022 (T+90)
142 shares@ US$2.691.3% of flowCommon StockSEC:0001209191-21-063235:0
Canonical exit: 30 Dec 2021 (T+90)
142 shares@ US$2.881.4% of flowCommon StockSEC:0001209191-21-058530:0
Canonical exit: 30 Nov 2021 (T+90)
142 shares@ US$3.341.6% of flowCommon StockSEC:0001209191-21-055485:0
Canonical exit: 31 Oct 2021 (T+90)
142 shares@ US$3.181.6% of flowCommon StockSEC:0001209191-21-051441:0
Canonical exit: 6 Oct 2021 (T+90)
1,000 shares@ US$3.2211.0% of flowCommon StockSEC:0001209191-21-039932:0
269 sharesCommon StockSEC:0001437749-16-025117:0
25 of 26 declarations
About Galante Joseph C
Galante Joseph C is Administrateur and a declarant for Cumberland Pharmaceuticals INC, Pinnacle Financial Partners INC and Avenue Financial Holdings, Inc. Across 26 filings, all 26 are included in the recent sample, with 69688 EUR of buys and 0 EUR of sells, between 2016-01-29 and 2026-03-20.
